DESIREE BENSON: Open Payments
NPI 1245980101 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 46 payments from 12 companies in 2025. Trend: 2023 $2,892 · 2024 $2,263 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $367 |
| C. R. Bard, Inc. & Subsidiaries | 18 | $165 |
| Boston Scientific Corporation | 3 | $87 |
| Endo USA, Inc. | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Procept Biorobotics Corporation | 1 | $39 |
| UROGEN PHARMA, INC. | 2 | $32 |
| PFIZER INC. | 1 | $28 |
| TOLMAR, INC. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
Products named: GEMTESA, ORGOVYX, XTANDI, AVEED, Nubeqa, AQUABEAM ROBOTIC SYSTEM, ENROUTE Transcarotid Neuroprotection System, JELMYTO.
Industry payments across TX — which companies pay providers there.
